Swine atrophic rhinitis inactivated vaccine and preparation method thereof
A technology for atrophic rhinitis and inactivated vaccines, which is applied in the field of porcine atrophic rhinitis inactivated vaccines and its preparation, can solve the problems of poor versatility of toxins, and achieve the effects of improving immunogenicity, reducing incomplete absorption, and shortening production time
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0034] Example 1 Preparation of porcine atrophic rhinitis inactivated vaccine
[0035] 1 Source and identification of the bacterial species in the embodiment of the present invention
[0036] 1.1 Source of strains
[0037] Porcine toxin-producing Pasteurella multocida ZXT+Pm strain deposit number CCTCC M 20211427
[0038] ZXT-Pm, Bordetella bronchiseptica AHBb strain with deposit number CCTCC M 20211379 were isolated, identified, stored and supplied by the Key Laboratory of Bacteriology, Ministry of Agriculture, Nanjing Agricultural University. The recombinant expression strain Rosetta-rPMT-N deposit number CCTCC M 20211371, and the recombinant expression strain Rosetta-rPMT-C deposit number CCTCC M 20211372 were constructed, identified, kept and supplied by the Key Laboratory of Bacteriology, Ministry of Agriculture, Nanjing Agricultural University.
[0039] 1.2 Identification of strains
[0040] 1.2.1 Porcine D-type toxin-producing Pasteurella multocida strain ZXT+Pm
[...
Embodiment 2
[0072] The preparation of embodiment 2 porcine atrophic rhinitis inactivated vaccine 2
[0073] The strain and the inactivation of the strain, the expression and purification of rPMT-N and rPMT-C are the same as in Example 1.
Embodiment 3
[0074] The preparation of embodiment 3 porcine atrophic rhinitis inactivated vaccine 3
[0075] The strain and the inactivation of the strain, the expression and purification of rPMT-N and rPMT-C are the same as in Example 1.
[0076] The ratio of each antigen in Example 2 and Example 3 is shown in Table 1 below.
[0077] Table 1 The composition ratio of porcine atrophic rhinitis inactivated vaccine
[0078]
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com